NM_001130987.2:c.3191G>A
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM1PM5PP3PP5_Very_Strong
The NM_001130987.2(DYSF):c.3191G>A(p.Arg1064His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,614,016 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1064C) has been classified as Uncertain significance.
Frequency
Consequence
NM_001130987.2 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive limb-girdle muscular dystrophyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- neuromuscular disease caused by qualitative or quantitative defects of dysferlinInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
- autosomal recessive limb-girdle muscular dystrophy type 2BInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- distal myopathy with anterior tibial onsetInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- congenital myopathy, Paradas typeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Miyoshi myopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DYSF | ENST00000410020.8 | c.3191G>A | p.Arg1064His | missense_variant | Exon 29 of 56 | 1 | NM_001130987.2 | ENSP00000386881.3 | ||
| DYSF | ENST00000258104.8 | c.3137G>A | p.Arg1046His | missense_variant | Exon 29 of 55 | 1 | NM_003494.4 | ENSP00000258104.3 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152212Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000200 AC: 5AN: 250544 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461686Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 727158 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152330Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74490 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Miyoshi muscular dystrophy 1 Pathogenic:4
- -
The variant c.3191G>A(p.Arg1064His) in DYSF gene has been observed in homozygous or compound heterozygous state in several individuals affected with Miyoshi myopathy and was observed to segregate with disease in a family (Xi J et al). The amino acid Arg at position 1064 is changed to a His changing protein sequence and it might alter its composition and physico-chemical properties. The variant has been reported with the allele frequency of 0.002128% in gnomAD and is novel (not in any individual) in 1000 GenomeS. This variant has been reported to the ClinVar database as Pathogenic. The variant is predicted to be damaging by both SIFT and PolyPhen2. The residue is conserved across species. The amino acid change p.Arg1064His in DYSF is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as pathogenic. -
A known missense variant, c.3191G>A in exon 29 of DYSF was identified in a homozygous state in the proband (Aoki et al., 2001; Accession: VCV000006675.33). Sanger validation and segregation analysis showed that the variant was present in homozygous state in the proband and heterozygous state in her mother. The father’s sample was not available for testing. The variant is present in 24 individuals in heterozygous state and absent in homozygous state in gnomAD (v4.1.0). This variant is absent in homozygous and/or homozygous state in our in-house database of 3274 exomes. In silico prediction tools (MutationTaster, CADD_phred, and REVEL) have predicted the variant to be damaging to DYSF protein function. Bi-allelic variants in DYSF gene are known to be associated with Miyoshi muscular dystrophy 1. -
- -
Autosomal recessive limb-girdle muscular dystrophy type 2B Pathogenic:3
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
The missense variant p.R1046H in DYSF (NM_003494.4) has been reported previously in compound heterozygous state in affected individuals (Krahn M et al; Charavorty S et al). The variant has been submitted to ClinVar as Pathogenic/Likely Pathogenic. The p.R1046H (0.002%)variant is observed in 6 alleles in heterozygous state in the gnomAD database and has not been observed in homozygous state. The p.R1046H missense variant is predicted to be damaging by both SIFT and PolyPhen2. The arginine residue at codon 1046 of DYSF is conserved in all mammalian species. The nucleotide c.3137 in DYSF is predicted conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Likely Pathogenic. -
- -
not provided Pathogenic:2
- -
- -
Distal myopathy with anterior tibial onset;C1850889:Autosomal recessive limb-girdle muscular dystrophy type 2B;C4551973:Miyoshi muscular dystrophy 1 Pathogenic:1
- -
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 1046 of the DYSF protein (p.Arg1046His). This variant is present in population databases (rs121908958, gnomAD 0.01%). This missense change has been observed in individual(s) with Miyoshi myopathy (PMID: 11468312, 18853459, 25591676, 27647186). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 6675). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt DYSF protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at